The Biden administration’s pandemic agenda must not ignore superbugs

  04 March 2021

What if another devastating pandemic came on the heels of Covid-19?

Unfortunately, that looks increasingly possible. For years, the antibiotics used to fight various bacterial infections have grown gradually less effective. If current trends continue, these antibiotics could stop working altogether in the near future, leaving humanity vulnerable to deadly, drug-resistant “superbugs.”

Preventing this public health threat will require an aggressive, federally backed effort to develop new and more potent antibiotics. As the Biden administration begins thinking about pandemic preparedness, it should focus on jump-starting innovation in developing new antimicrobial drugs.

Further reading: Stat News
Author(s): Michelle McMurry-Heath
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support kindly provided by

Antimicrobial Resistance Fighter Coalition

CDD VAULT Complexity Simplified





Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!